Wells Fargo & Company MN Sells 9,963 Shares of Agilent Technologies Inc (A)

Wells Fargo & Company MN decreased its holdings in shares of Agilent Technologies Inc (NYSE:A) by 0.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,974,251 shares of the medical research company’s stock after selling 9,963 shares during the quarter. Wells Fargo & Company MN owned approximately 0.93% of Agilent Technologies worth $209,802,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. SRS Capital Advisors Inc. raised its position in Agilent Technologies by 75.9% during the second quarter. SRS Capital Advisors Inc. now owns 1,791 shares of the medical research company’s stock worth $110,000 after acquiring an additional 773 shares in the last quarter. Moneta Group Investment Advisors LLC raised its position in Agilent Technologies by 391.7% during the second quarter. Moneta Group Investment Advisors LLC now owns 6,023 shares of the medical research company’s stock worth $158,000 after acquiring an additional 4,798 shares in the last quarter. TRUE Private Wealth Advisors bought a new stake in Agilent Technologies during the third quarter worth $181,000. Bray Capital Advisors raised its position in Agilent Technologies by 12,000.0% during the second quarter. Bray Capital Advisors now owns 3,025 shares of the medical research company’s stock worth $187,000 after acquiring an additional 3,000 shares in the last quarter. Finally, AMG National Trust Bank bought a new stake in Agilent Technologies during the third quarter worth $212,000.

Several analysts have issued reports on A shares. ValuEngine raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Friday, November 2nd. Deutsche Bank increased their price objective on shares of Agilent Technologies from $77.00 to $80.00 and gave the company a “buy” rating in a research report on Wednesday, August 15th. Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price objective on the stock in a research report on Tuesday, August 7th. Goldman Sachs Group reissued a “buy” rating and issued a $82.00 price objective (up from $77.00) on shares of Agilent Technologies in a research report on Tuesday, September 18th. Finally, Morgan Stanley increased their price objective on shares of Agilent Technologies from $84.00 to $86.00 and gave the company an “overweight” rating in a research report on Wednesday, October 10th. One investment analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $77.44.

A opened at $67.79 on Friday. Agilent Technologies Inc has a 1-year low of $60.42 and a 1-year high of $75.00. The company has a debt-to-equity ratio of 0.39, a quick ratio of 3.00 and a current ratio of 3.62. The company has a market capitalization of $21.03 billion, a PE ratio of 28.72, a P/E/G ratio of 2.06 and a beta of 1.35.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Tuesday, August 14th. The medical research company reported $0.67 earnings per share for the quarter, beating analysts’ consensus estimates of $0.63 by $0.04. Agilent Technologies had a net margin of 6.20% and a return on equity of 18.61%. The company had revenue of $1.20 billion for the quarter, compared to the consensus estimate of $1.20 billion. During the same period last year, the company posted $0.59 EPS. The firm’s quarterly revenue was up 8.0% compared to the same quarter last year. On average, analysts expect that Agilent Technologies Inc will post 2.71 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 24th. Investors of record on Tuesday, October 2nd were issued a $0.149 dividend. The ex-dividend date of this dividend was Monday, October 1st. This represents a $0.60 dividend on an annualized basis and a yield of 0.88%. Agilent Technologies’s dividend payout ratio (DPR) is presently 25.42%.

In other Agilent Technologies news, Director Heidi Fields sold 5,482 shares of the firm’s stock in a transaction that occurred on Tuesday, September 11th. The shares were sold at an average price of $67.73, for a total transaction of $371,295.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Paul N. Clark sold 2,876 shares of the firm’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $68.60, for a total transaction of $197,293.60. The disclosure for this sale can be found here.

COPYRIGHT VIOLATION NOTICE: “Wells Fargo & Company MN Sells 9,963 Shares of Agilent Technologies Inc (A)” was originally published by WKRB News and is the sole property of of WKRB News. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://www.wkrb13.com/2018/11/09/wells-fargo-company-mn-sells-9963-shares-of-agilent-technologies-inc-a.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Featured Story: How to Invest in Growth Stocks

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply